A recombinant monoclonal antibody against TP53, its preparation method and application
CN118994386BActive Publication Date: 2025-10-28GANNAN INST OF INNOVATION & TRANSLATIONAL MEDICINE
-1 Cites 0 Cited by
Patent Information
- Application Number
- CN202411369084.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-29
- Publication Date
- 2025-10-28
- Estimated Expiration
- 2044-09-29
Smart Images

Figure CN118994386B_ABST
Abstract
This invention belongs to the field of biotechnology, specifically relating to an anti-TP53 recombinant monoclonal antibody, its preparation method, and its application. The anti-TP53 recombinant monoclonal antibody includes a heavy chain variable region and a light chain variable region; the heavy chain variable region includes any one of the amino acid sequences shown in SEQ ID NO. 6-9; the light chain variable region includes the amino acid sequence shown in SEQ ID NO. 10. This invention utilizes hybridoma technology to prepare a mouse anti-human TP53 recombinant monoclonal antibody. This recombinant antibody has a well-defined structure, high titer, and better stability, effectively solving the problems existing in traditional hybridoma technology.
Need to check novelty before this filing date? Find Prior Art